Entrada Therapeutics Inc (TRDA)
SG&A Expense Growth
3.63%
Quarterly · Period ending:
TRDA SG&A Expense Growth
Latest reported3.63%period ending
Latest reported3.63%period ending
TRDA Quarterly SG&A Growth (QoQ) (0.00% → 3.63%)
Latest values, visible window
High-resolution chart · PNG
TRDA sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 3.6349% | |
| 6.0105% | |
| -7.3175% | |
| -5.6583% | |
| 6.3072% | |
| 4.2094% | |
| -1.1233% | |
| 7.958% | |
| -1.7342% | |
| 8.6338% | |
| 14.8699% | |
| -7.7978% | |
| 2.9101% | |
| -19.7696% | |
| 41.7885% | |
| -4.8541% | |
| 14.0059% | |
| 5.4936% | |
| 58.3485% | |
| 24.9919% | |
| 41.9816% | |
| 8.663% | |
| 56.8735% | |
| 10.9368% | |
| 0% | |
| 0% |